{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:58:10Z","timestamp":1790542690324,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.heliyon.2024.e32729","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T20:38:23Z","timestamp":1718224703000},"page":"e32729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Structural screening and molecular simulation identify potential ligands against the K700E hot spot variant and functional pockets of SF3B1 to modulate splicing in myelodysplastic syndrome"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6762-5633","authenticated-orcid":false,"given":"Rolando","family":"Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Atis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8563-8059","authenticated-orcid":false,"given":"Andrew","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7109-5906","authenticated-orcid":false,"given":"Prasad","family":"Koduru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.heliyon.2024.e32729_bib1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s10147-019-01462-6","article-title":"Genetic abnormalities and pathophysiology of MDS","volume":"24","author":"Hosono","year":"2019","journal-title":"Int. J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e32729_bib2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.2011.36.1824","article-title":"Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited","volume":"30","author":"Jerez","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"7367","key":"10.1016\/j.heliyon.2024.e32729_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e32729_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100791","article-title":"Current and emerging strategies for management of myelodysplastic syndromes","volume":"48","author":"Saygin","year":"2021","journal-title":"Blood Rev."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e32729_bib5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cell.2009.02.009","article-title":"The spliceosome: design principles of a dynamic RNP machine","volume":"136","author":"Wahl","year":"2009","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.heliyon.2024.e32729_bib6","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts","volume":"365","author":"Papaemmanuil","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.heliyon.2024.e32729_bib7","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia","volume":"365","author":"Wang","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"7403","key":"10.1016\/j.heliyon.2024.e32729_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature11143","article-title":"Whole-genome analysis informs breast cancer response to aromatase inhibition","volume":"486","author":"Ellis","year":"2012","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e32729_bib9","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1158\/2159-8290.CD-13-0330","article-title":"SF3B1 mutations are associated with alternative splicing in uveal melanoma","volume":"3","author":"Furney","year":"2013","journal-title":"Cancer Discov."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e32729_bib10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ng.620","article-title":"Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes","volume":"42","author":"Nikoloski","year":"2010","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e32729_bib11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2017-06-789669","article-title":"Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies","volume":"131","author":"Yang","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32729_bib12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/cas.12317","article-title":"High antitumor activity of pladienolide B and its derivative in gastric cancer","volume":"105","author":"Sato","year":"2014","journal-title":"Cancer Sci."},{"issue":"22","key":"10.1016\/j.heliyon.2024.e32729_bib13","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1002\/cmdc.202000642","article-title":"A Comprehensive overview of structure-activity relationships of small-molecule splicing modulators targeting SF3B1 as anticancer agents","volume":"15","author":"Zhang","year":"2020","journal-title":"ChemMedChem"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e32729_bib14","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1038\/s41375-021-01328-9","article-title":"Phase I first-in-human dose escalation study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms","volume":"35","author":"Steensma","year":"2021","journal-title":"Leukemia"},{"issue":"20","key":"10.1016\/j.heliyon.2024.e32729_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011222","article-title":"Investigating the molecular mechanism of H3B-8800: a splicing modulator inducing preferential lethality in spliceosome-mutant cancers","volume":"22","author":"Spinello","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e32729_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/biom9100633","article-title":"Disclosing the impact of carcinogenic SF3b mutations on pre-mRNA recognition via all-atom simulations","volume":"9","author":"Borisek","year":"2019","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32729_bib17","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1021\/acs.jcim.9b00635","article-title":"Exploiting cryo-EM structural information and all-atom simulations to decrypt the molecular mechanism of splicing modulators","volume":"60","author":"Borisek","year":"2020","journal-title":"J. Chem. Inf. Model."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e32729_bib18","first-page":"4837","article-title":"SF3b1 mutations associated with myelodysplastic syndromes alter the fidelity of branchsite selection in yeast","volume":"45","author":"Carrocci","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e32729_bib19","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/onc.2016.279","article-title":"Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3' splice sites within RNA secondary structures","volume":"36","author":"Kesarwani","year":"2017","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32729_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/biom10050680","article-title":"In silico analysis of a highly mutated gene in cancer provides insight into abnormal mRNA splicing: splicing factor 3B subunit 1(K700E) mutant","volume":"10","author":"Samy","year":"2020","journal-title":"Biomolecules"},{"issue":"11\u201312","key":"10.1016\/j.heliyon.2024.e32729_bib21","article-title":"Structures of SF3b1 reveal a dynamic Achilles heel of spliceosome assembly: implications for cancer-associated abnormalities and drug discovery","volume":"1862","author":"Maji","year":"2019","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32729_bib22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.heliyon.2024.e32729_bib23","series-title":"QuickProp","author":"Release","year":"2018"},{"issue":"W1","key":"10.1016\/j.heliyon.2024.e32729_bib24","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32729_bib25","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1038\/s41598-021-83626-x","article-title":"Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein","volume":"11","author":"Opo","year":"2021","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e32729_bib26","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1080\/07391102.2020.1850528","article-title":"In silico screening predicts common cold drug Dextromethorphan along with Prednisolone and Dexamethasone can be effective against novel Coronavirus disease (COVID-19)","volume":"40","author":"Sarkar As","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"18","key":"10.1016\/j.heliyon.2024.e32729_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24183387","article-title":"Molecular docking and dynamics simulation of protein beta-tubulin and antifungal cyclic lipopeptides","volume":"24","author":"Cob-Calan","year":"2019","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e32729_bib28","first-page":"2021","article-title":"Drug repurposing approach against novel coronavirus disease (COVID-19) through virtual screening targeting SARS-CoV-2 main protease","volume":"10","author":"Chowdhury Mrc","year":"2021","journal-title":"Biology"},{"issue":"20","key":"10.1016\/j.heliyon.2024.e32729_bib29","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/jnci\/djt257","article-title":"Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors","volume":"105","author":"Scott","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e32729_bib30","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202301955","article-title":"SF3B1 mutation-mediated sensitization to H3B-8800 splicing inhibitor in chronic lymphocytic leukemia","volume":"6","author":"Lopez-Oreja","year":"2023","journal-title":"Life Sci. Alliance"},{"issue":"19","key":"10.1016\/j.heliyon.2024.e32729_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194927","article-title":"SF3B1 mutations in hematological malignancies","volume":"14","author":"Cilloni","year":"2022","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e32729_bib32","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ajh.23264","article-title":"Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management","volume":"87","author":"Garcia-Manero","year":"2012","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e32729_bib33","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nchembio.2007.18","article-title":"Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA","volume":"3","author":"Kaida","year":"2007","journal-title":"Nat. Chem. Biol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e32729_bib34","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1021\/acs.nanolett.0c01757","article-title":"Chiral protein supraparticles for tumor suppression and synergistic immunotherapy: an enabling strategy for bioactive supramolecular chirality construction","volume":"20","author":"Yan","year":"2020","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32729_bib35","first-page":"100","article-title":"Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative","volume":"56","author":"Buchdunger","year":"1996","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.heliyon.2024.e32729_bib36","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s40265-019-01194-x","article-title":"Apalutamide: a review in non-metastatic castration-resistant prostate cancer","volume":"79","author":"Al-Salama","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.heliyon.2024.e32729_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104851","article-title":"In silico methods and tools for drug discovery","volume":"137","author":"Shaker","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.heliyon.2024.e32729_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100728","article-title":"The role of alternative splicing in cancer: from oncogenesis to drug resistance","volume":"53","author":"Sciarrillo","year":"2020","journal-title":"Drug Resist. Updates"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e32729_bib39","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.stem.2016.08.003","article-title":"RNA splicing modulation selectively impairs leukemia stem cell maintenance in secondary human AML","volume":"19","author":"Crews","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e32729_bib40","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.7164\/antibiotics.49.1196","article-title":"New antitumor substances, FR901463, FR901464 and FR901465. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities","volume":"49","author":"Nakajima","year":"1996","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"24","key":"10.1016\/j.heliyon.2024.e32729_bib41","doi-asserted-by":"crossref","first-page":"10033","DOI":"10.1021\/jm401370h","article-title":"Optimization of antitumor modulators of pre-mRNA splicing","volume":"56","author":"Lagisetti","year":"2013","journal-title":"J. Med. Chem."},{"issue":"26","key":"10.1016\/j.heliyon.2024.e32729_bib42","doi-asserted-by":"crossref","first-page":"22734","DOI":"10.18632\/oncotarget.4212","article-title":"The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia","volume":"6","author":"Xargay-Torrent","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e32729_bib43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10637-013-0046-5","article-title":"A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors","volume":"32","author":"Hong","year":"2014","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.heliyon.2024.e32729_bib44","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2019-123854","article-title":"Ades lea: results of a clinical trial of H3B-8800, a splicing modulator, in patients with myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) or chronic myelomonocytic leukemia (CMML)","volume":"134","author":"Steensma Dpw","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e32729_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.dnarep.2018.04.003","article-title":"Multiple roles of the splicing complex SF3B in DNA end resection and homologous recombination","volume":"66\u201367","author":"Prados-Carvajal","year":"2018","journal-title":"DNA Repair"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e32729_bib46","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood-2019-124787","article-title":"The SF3b splicing complex regulates DNA damage response in acute lymphoblastic leukemia","volume":"134","author":"Sankar","year":"2019","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e32729_bib47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11882-022-01040-3","article-title":"Is icatibant safe for the treatment of hereditary angioedema during pregnancy?","volume":"22","author":"Simac","year":"2022","journal-title":"Curr. Allergy Asthma Rep."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e32729_bib48","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/23744235.2023.2200563","article-title":"Icatibant in viral infections","volume":"55","author":"Mustonen","year":"2023","journal-title":"Inf. Disp."},{"key":"10.1016\/j.heliyon.2024.e32729_bib49","series-title":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases","year":"2012"},{"issue":"18","key":"10.1016\/j.heliyon.2024.e32729_bib50","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.2165\/00003495-200565180-00011","article-title":"Goserelin: a review of its use in the treatment of early breast cancer in premenopausal and perimenopausal women","volume":"65","author":"Cheer","year":"2005","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e32729_bib51","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s40265-015-0409-7","article-title":"Diquafosol ophthalmic solution 3 %: a review of its use in dry eye","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024087607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024087607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:44:22Z","timestamp":1790541862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024087607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2405844024087607"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32729","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural screening and molecular simulation identify potential ligands against the K700E hot spot variant and functional pockets of SF3B1 to modulate splicing in myelodysplastic syndrome","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e32729"}}